Trials / Completed
CompletedNCT00426452
A Drug-drug Interaction Study of Oral 1250 mg of Vatalinib Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor in Healthy Sterile or Postmenopausal Female Volunteers
A Phase IB, Open Label, Single Center, Drug-drug Interaction Study of Oral 1250 mg of PTK787/ZK 222584 Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor (Omeprazole) in Healthy Sterile or Postmenopausal Female Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- Novartis · Industry
- Sex
- Female
- Age
- 35 Years – 70 Years
- Healthy volunteers
- —
Summary
This study will determine the effect of acidic drugs such as proton-pump inhibitors on the pharmacokinetics of Vatalinib under fasting and fed conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vatalinib |
Timeline
- Start date
- 2006-07-01
- First posted
- 2007-01-24
- Last updated
- 2009-11-19
Source: ClinicalTrials.gov record NCT00426452. Inclusion in this directory is not an endorsement.